WallStreetZenWallStreetZen

NASDAQ: PVLA
Palvella Therapeutics Inc Stock Ownership - Who owns Palvella Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Palvella Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kathleen GoinChief Operating Officer2025-12-172,154$7.14
$15.38kBuy
Kathleen GoinChief Operating Officer2025-12-172,148$9.08
$19.50kBuy
Kathleen GoinChief Operating Officer2025-12-174,302$96.47
$415.02kSell
Kathleen GoinChief Operating Officer2025-11-192,802$86.51
$242.39kSell
Kathleen GoinChief Operating Officer2025-11-192,154$7.14
$15.38kBuy
Kathleen GoinChief Operating Officer2025-11-192,148$9.08
$19.50kBuy
Kathleen GoinChief Operating Officer2025-11-191,500$85.72
$128.58kSell
George M. JenkinsDirector2025-04-092,500$20.13
$50.33kBuy
George M. JenkinsDirector2025-04-092,490$20.27
$50.47kBuy

1 of 1

PVLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PVLA insiders and whales buy or sell their stock.

PVLA Shareholders

What type of owners hold Palvella Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aquilo Capital Management LLC31.05%3,675,530$367.11MInsider
Wes Kaupinen13.58%1,607,228$160.53MInsider
Bvf Inc9.81%1,161,249$115.99MInstitution
Suvretta Capital Management LLC6.95%822,400$82.14MInstitution
Frazier Life Sciences Management LP6.10%722,400$72.15MInstitution
First Light Asset Management LLC4.58%541,544$54.09MInstitution
Vanguard Group Inc4.18%494,656$49.41MInstitution
Blackrock Inc4.12%487,616$48.70MInstitution
Perceptive Advisors LLC3.34%395,093$39.46MInstitution
Woodline Partners LP2.92%345,749$34.53MInstitution

1 of 3

PVLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PVLA57.88%42.12%Net BuyingNet Buying
SEPN66.24%33.76%Net BuyingNet Selling
SVRA39.35%60.65%Net SellingNet Selling
OMER46.33%5.09%
PHAR0.01%0.00%
View Top Biotech Stocks

Palvella Therapeutics Stock Ownership FAQ

Who owns Palvella Therapeutics?

Palvella Therapeutics (NASDAQ: PVLA) is owned by 72.03% institutional shareholders, 52.42% Palvella Therapeutics insiders, and 0.00% retail investors. Aquilo Capital Management LLC is the largest individual Palvella Therapeutics shareholder, owning 3.68M shares representing 31.05% of the company. Aquilo Capital Management LLC's Palvella Therapeutics shares are currently valued at $384.72M.

If you're new to stock investing, here's how to buy Palvella Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.